Reading is good for you...
Reading about what's good for you is even better.

August 8, 2022

August 10, 2022

August 2, 2022
Prescription required
Get your Zarontin delivered at your door for FREE
Available Form:
Capsule
Manufacturer name:
Erfa
Generic name:
ethosuximide
Strength:
250mg
Zarontin (Ethosuximide) is used to manage and prevent certain types of seizures (those caused by absence [petit mal] Epilepsy). It may be used at the same time as other medications that are used to control different types of seizures.
Get Zarontin delivered for free
Save time. Skip the line. Join Pocketpills and fill your prescriptions online.
Insurance coverage
We accept all insurance plans
Estimated copay
$2.72
Drug cost
$0.61
Dispensing fee
$12.99
Delivery cost
FREE
Insurance coverage
$10.88
**Actual price will depend on the insurance coverage in your province
Zarontin (Ethosuximide) is used to manage and prevent certain types of seizures (those caused by absence [petit mal] Epilepsy). It may be used at the same time as other medications that are used to control different types of seizures. It helps to control seizures by working on the central nervous system.
Zarontin (Ethosuximide) may be available under multiple brand names and/or in several different forms. Any specific brand name of Zarontin (Ethosuximide) may not be available in all of the forms or approved for all of the conditions discussed here. As well, some forms of Zarontin (Ethosuximide) may not be used for all of the conditions discussed here.
Your doctor may have suggested Zarontin (Ethosuximide) for conditions other than those listed in these drug information articles. If you have not discussed this with your doctor or are not sure why you are taking Zarontin (Ethosuximide), speak to your doctor. Do not stop taking Zarontin (Ethosuximide) without consulting your doctor.
Do not give Zarontin (Ethosuximide) to anyone else, even if they have the same symptoms as you do. It can be harmful for people to take Zarontin (Ethosuximide) if their doctor has not prescribed it.
Adults: The dose of Zarontin (Ethosuximide) varies according to the needs and age of the person using the medication and their response to treatment. Often a dose of 1 g to 1.5 g daily in divided doses controls seizures in adults.
Children: The dose for children 3 to 6 years of age is 250 mg daily. For older children, it is 500 mg daily taken in divided doses.
Use an oral syringe to measure each dose of the liquid, as it gives a more accurate measurement than household teaspoons.
Many things can affect the dose of medication that a person needs, such as body weight, other medical conditions, and other medications. If your doctor has recommended a dose different from the ones listed here, do not change the way that you are taking the medication without consulting your doctor.
It is important to take Zarontin (Ethosuximide) exactly as prescribed by your doctor. If you miss a dose, take it as soon as possible and continue with your regular schedule. If it is almost time for your next dose, skip the missed dose and continue with your regular dosing schedule. Do not take a double dose to make up for a missed one. If you are not sure what to do after missing a dose, contact your doctor or pharmacist for advice.
Store Zarontin (Ethosuximide) at room temperature in a dry environment. Zarontin (Ethosuximide) capsules are sensitive to conditions of high humidity, which can result in decreased effectiveness of the medication.
Do not dispose of medications in wastewater (e.g. down the sink or in the toilet) or in household garbage. Ask your pharmacist how to dispose of medications that are no longer needed or have expired.
Many medications can cause side effects. A side effect is an unwanted response to a medication when it is taken in normal doses. Side effects can be mild or severe, temporary or permanent.
The side effects listed below are not experienced by everyone who takes Zarontin (Ethosuximide). If you are concerned about side effects, discuss the risks and benefits of Zarontin (Ethosuximide) with your doctor.
The following side effects have been reported by at least 1% of people taking Zarontin (Ethosuximide). Many of these side effects can be managed, and some may go away on their own over time.
Contact your doctor if you experience these side effects and they are severe or bothersome. Your pharmacist may be able to advise you on managing side effects.
Although most of these side effects listed below don't happen very often, they could lead to serious problems if you do not seek medical attention.
Check with your doctor as soon as possible if any of the following side effects occur:
Stop taking the medication and seek immediate medical attention if any of the following occur:
Some people may experience side effects other than those listed. Check with your doctor if you notice any symptom that worries you while you are taking Zarontin (Ethosuximide).
Capsules
Each soluble gelatin capsule, embossed "PD 237" contains 250 mg of Zarontin (Ethosuximide). Nonmedicinal ingredients: D&C Yellow No. 10, FD&C Red No. 3, gelatin, glycerin, polyethylene glycol, and sorbitol.
Syrup
Each 5 mL contains 250 mg of Zarontin (Ethosuximide). Nonmedicinal ingredients: alcohol, citric acid anhydrous, FD&C Yellow No. 6, flavouring agents, glycerin, purified water, saccharin sodium, sodium benzoate, sodium citrate, sucrose, and vanillin. Gluten-, lactose-, parabens-, sulfite-, and tartrazine-free.
Do not take Zarontin (Ethosuximide) if you:
There may be an interaction between Zarontin (Ethosuximide) and any of the following:
If you are taking any of these medications, speak with your doctor or pharmacist. Depending on your specific circumstances, your doctor may want you to:
An interaction between two medications does not always mean that you must stop taking one of them. Speak to your doctor about how any drug interactions are being managed or should be managed.
Medications other than those listed above may interact with Zarontin (Ethosuximide). Tell your doctor or prescriber about all prescription, over-the-counter (non-prescription), and herbal medications you are taking. Also tell them about any supplements you take. Since caffeine, alcohol, the Nicotine from cigarettes, or street drugs can affect the action of many medications, you should let your prescriber know if you use them.
Before you begin using a medication, be sure to inform your doctor of any medical conditions or Allergies you may have, any medications you are taking, whether you are pregnant or breast-feeding, and any other significant facts about your health. These factors may affect how you should use Zarontin (Ethosuximide).
Blood disorders: Blood disorders, although infrequent, may be serious and have been reported to be associated with the use of Zarontin (Ethosuximide). Zarontin (Ethosuximide) can decrease the number of neutrophils (a type of white blood cell that helps fight infection), red blood cells (which carry oxygen), and platelets (which help your blood to clot). Your doctor may do blood tests to monitor this. If you notice any signs of infection (e.g., fever, chills, or sore throat) or unusual bleeding or bruising, contact your doctor immediately.
Drowsiness/reduced alertness: Zarontin (Ethosuximide) may impair the mental or physical abilities required for potentially dangerous activities such as driving or operating machinery. Avoid driving, operating machinery, or performing other potentially hazardous tasks until you have determined how Zarontin (Ethosuximide) affects you.
Liver function: Liver disease or reduced liver function may cause Zarontin (Ethosuximide) to build up in the body, causing side effects. If you have liver problems, discuss with your doctor how Zarontin (Ethosuximide) may affect your medical condition, how your medical condition may affect the dosing and effectiveness of Zarontin (Ethosuximide), and whether any special monitoring is needed.
People taking Zarontin (Ethosuximide) may have changes in liver function that produce abnormal liver test results. Your doctor will recommend regular liver tests while you are taking Zarontin (Ethosuximide).
Lupus: Cases of systemic lupus erythematosus (SLE) have been reported with the use of Zarontin (Ethosuximide). If you have SLE, discuss with your doctor how Zarontin (Ethosuximide) may affect your medical condition, how your medical condition may affect the dosing and effectiveness of Zarontin (Ethosuximide), and whether any special monitoring is needed.
Seizures: Zarontin (Ethosuximide) may increase the frequency of experiencing tonic-clonic, or grand mal seizures for people that experience mixed types of seizures. If you experience an increase in the number of seizures you have, or different types of seizures, contact your doctor as soon as possible.
Suicidal behaviour: People taking Zarontin (Ethosuximide) may feel that they want to hurt themselves or others. These symptoms may occur within several weeks after starting Zarontin (Ethosuximide). If you experience these side effects or notice them in a family member who is taking Zarontin (Ethosuximide), contact your doctor immediately. You should be closely monitored by your doctor for emotional and behaviour changes while taking Zarontin (Ethosuximide).
Pregnancy: Women subject to major seizures should not stop taking Zarontin (Ethosuximide) during pregnancy. For women subject to minor seizures, the risk of stopping the medication prior to or during pregnancy should be weighed against the risk of birth defects. If you become pregnant while taking Zarontin (Ethosuximide), contact your doctor right away.
Breast-feeding: Zarontin (Ethosuximide) passes into breast milk. If you are a breast-feeding mother and are taking Zarontin (Ethosuximide), it may affect your baby. Talk to your doctor about whether you should continue breast-feeding.
Children: The safety and effectiveness of Zarontin (Ethosuximide) have not been established for children less than 3 years of age.
References
All material © 1996-2021 MediResource Inc. Terms and conditions of use. The contents herein are for informational purposes only. Always seek the advice of your physician or other qualified health providers with any questions you may have regarding a medical condition.
August 8, 2022
August 10, 2022
August 2, 2022